Clinical Study of Oral IGF-1R Inhibitor in Subjects With Advanced Refractory Solid Tumors
NCT01779336
·
clinicaltrials.gov ↗
PHASE1
Phase
SUSPENDED
Status
70
Enrollment
INDUSTRY
Sponsor class
Stopped
Sponsor decision not related to patient safety
Conditions
Advanced Refractory Solid Tumors
Interventions
DRUG:
PL225B
Sponsor
Piramal Enterprises Limited